Sapient Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Sapient Capital’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,588	Closed	-$269K	–	468
2025 Q4	$269K	Hold	2,588	–	–	﹤0.01%	358
2025 Q3	$226K	Hold	2,588	–	–	﹤0.01%	361
2025 Q2	$228K	Hold	2,588	–	–	﹤0.01%	349
2025 Q1	$236K	Buy	+2,588	New	+$233K	﹤0.01%	328

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Sapient Capital's PPH Position: Q1 2026 in Review

Sapient Capital sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2026, closing a stake of 2,588 shares — an estimated $269K sold.

Sapient Capital first reported a position in PPH in Q1 2025 and held it in 4 quarters. The position peaked at $269K in Q4 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Sapient Capital reported no remaining VanEck Pharmaceutical ETF position as of Q1 2026 after selling out during the quarter.
Sapient Capital sold 2,588 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $269K.
Sapient Capital first reported a position in VanEck Pharmaceutical ETF in Q1 2025 and held it in 4 quarters.
Sapient Capital's VanEck Pharmaceutical ETF position peaked at $269K in Q4 2025.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Sapient Capital's 13F filing for Q1 2026, filed 8 Apr 2026.